Greystone Financial Group’s GSK GSK Stock Holding History

Greystone Financial Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-176,744	Closed	-$6.8M	–	108
2024 Q2	$6.8M	Sell	176,744 -67,070	-28%	-$2.82M	1.33%	34
2024 Q1	$10.5M	Buy	243,814 +224,262	+1,147%	+$9.25M	2.09%	14
2023 Q4	$725K	Sell	19,552 -188	-1%	-$6.75K	0.17%	69
2023 Q3	$716K	Buy	19,740 +1,022	+5%	+$36.3K	0.18%	65
2023 Q2	$667K	Sell	18,718 -154	-0.8%	-$5.52K	0.15%	73
2023 Q1	$671K	Sell	18,872 -1,914	-9%	-$67K	0.17%	67
2022 Q4	$730K	Sell	20,786 -554	-3%	-$18.5K	0.21%	58
2022 Q3	$628K	Buy	+21,340	New	+$809K	0.21%	57

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greystone Financial Group's GSK Position: Q3 2024 in Review

Greystone Financial Group sold out of GSK (GSK) in Q3 2024, closing a stake of 176,744 shares — an estimated $6.8M sold.

Greystone Financial Group first reported a position in GSK in Q3 2022 and held it in 8 quarters. The position peaked at $10.5M in Q1 2024. 900 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

Greystone Financial Group reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
Greystone Financial Group sold 176,744 GSK shares in Q3 2024, an estimated $6.8M.
Greystone Financial Group first reported a position in GSK in Q3 2022 and held it in 8 quarters.
Greystone Financial Group's GSK position peaked at $10.5M in Q1 2024.
900 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Greystone Financial Group's 13F filing for Q3 2024, filed 22 Oct 2024.